rs1085307884
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001453.3(FOXC1):c.380G>A(p.Arg127His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R127L) has been classified as Pathogenic.
Frequency
Consequence
NM_001453.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXC1 | NM_001453.3 | c.380G>A | p.Arg127His | missense_variant | Exon 1 of 1 | ENST00000645831.2 | NP_001444.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Axenfeld-Rieger syndrome type 3 Pathogenic:2
This variant disrupts the p.Arg127 amino acid residue in FOXC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24914578, 28979898; 28979898 24914578). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 127 of the FOXC1 protein (p.Arg127His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Axenfeld-Rieger syndrome (PMID: 11740218; Invitae). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 537389). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FOXC1 protein function. Experimental studies have shown that this missense change affects FOXC1 function (PMID: 14506133). For these reasons, this variant has been classified as Pathogenic. -
- -
FOXC1-related disorder Pathogenic:1
The FOXC1 c.380G>A variant is predicted to result in the amino acid substitution p.Arg127His. This variant has been reported in a mother and son with Axenfeld-Rieger syndrome, and it was determined the variant arose de novo in the mother (Kawase et al. 2001. PubMed ID: 11740218). This variant has also been reported in two unrelated individuals with Axenfeld-Rieger syndrome (Zhang et al. 2021. PubMed ID: 34745210). Different variants that affect this same amino acid residue (p.Arg127Cys and p.Arg127Leu) have been reported in individuals with Axenfeld-Rieger syndrome (Khalil et al. 2017. PubMed ID: 28979898; Du et al. 2016. PubMed ID: 24914578). This c.380G>A (p.Arg127His) variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Given the evidence, we interpret c.380G>A (p.Arg127His) as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at